Lipocine Other Stockholder Equity from 2010 to 2025
| LPCN Stock | USD 3.07 0.09 2.85% |
Other Stockholder Equity | First Reported 2011-12-31 | Previous Quarter 220.5 M | Current Value 220.6 M | Quarterly Volatility 70.7 M |
Check Lipocine financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Lipocine's main balance sheet or income statement drivers, such as Interest Expense of 0.0, Selling General Administrative of 5.8 M or Other Operating Expenses of 14.9 M, as well as many indicators such as Dividend Yield of 0.0, Ptb Ratio of 0.68 or Book Value Per Share of 4.22. Lipocine financial statements analysis is a perfect complement when working with Lipocine Valuation or Volatility modules.
Lipocine | Other Stockholder Equity |
Latest Lipocine's Other Stockholder Equity Growth Pattern
Below is the plot of the Other Stockholder Equity of Lipocine over the last few years. It is Lipocine's Other Stockholder Equity historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Lipocine's overall financial position and show how it may be relating to other accounts over time.
| Other Stockholder Equity | 10 Years Trend |
|
Other Stockholder Equity |
| Timeline |
Lipocine Other Stockholder Equity Regression Statistics
| Arithmetic Mean | 134,072,486 | |
| Geometric Mean | 33,337,507 | |
| Coefficient Of Variation | 59.92 | |
| Mean Deviation | 61,142,426 | |
| Median | 147,492,307 | |
| Standard Deviation | 80,335,081 | |
| Sample Variance | 6453.7T | |
| Range | 253.1M | |
| R-Value | 0.90 | |
| Mean Square Error | 1358.1T | |
| R-Squared | 0.80 | |
| Slope | 15,126,129 | |
| Total Sum of Squares | 96805.9T |
Lipocine Other Stockholder Equity History
About Lipocine Financial Statements
Lipocine investors utilize fundamental indicators, such as Other Stockholder Equity, to predict how Lipocine Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
| Last Reported | Projected for Next Year | ||
| Other Stockholder Equity | 253.2 M | 147.6 M |
Check out the analysis of Lipocine Correlation against competitors. To learn how to invest in Lipocine Stock, please use our How to Invest in Lipocine guide.You can also try the Pattern Recognition module to use different Pattern Recognition models to time the market across multiple global exchanges.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Lipocine. If investors know Lipocine will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Lipocine listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.75) | Revenue Per Share | Quarterly Revenue Growth 137.519 | Return On Assets | Return On Equity |
The market value of Lipocine is measured differently than its book value, which is the value of Lipocine that is recorded on the company's balance sheet. Investors also form their own opinion of Lipocine's value that differs from its market value or its book value, called intrinsic value, which is Lipocine's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Lipocine's market value can be influenced by many factors that don't directly affect Lipocine's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Lipocine's value and its price as these two are different measures arrived at by different means. Investors typically determine if Lipocine is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Lipocine's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.